Total Payments
$2,483
2024 Payments
$479.17
Companies
24
Transactions
141
Medicare Patients
2,025
Medicare Billing
$145,383
Payment Breakdown by Category
Food & Beverage$2,483 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,483 | 141 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $691.92 | 53 | $0 (2024) |
| Gilead Sciences, Inc. | $275.25 | 13 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $221.24 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $218.29 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $212.54 | 9 | $0 (2023) |
| QOL Medical, LLC | $158.56 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $107.31 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $67.33 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $65.57 | 1 | $0 (2023) |
| Celgene Corporation | $64.80 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $479.17 | 25 | QOL Medical, LLC ($120.30) |
| 2023 | $1,098 | 61 | ABBVIE INC. ($390.97) |
| 2022 | $504.52 | 28 | Gilead Sciences, Inc. ($125.88) |
| 2021 | $400.84 | 27 | AbbVie Inc. ($136.75) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/05/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: GI | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Immunology | ||||||
| 10/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Immunology | ||||||
| 07/16/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.83 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: GI | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Immunology | ||||||
| 05/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.09 | General |
| 04/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Neuroscience | ||||||
| 03/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.58 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/28/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: GI | ||||||
| 02/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Immunology | ||||||
| 01/31/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: GI | ||||||
| 01/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 485 | 534 | $106,864 | $35,055 |
| 2022 | 6 | 448 | 502 | $100,439 | $31,819 |
| 2021 | 5 | 522 | 585 | $119,752 | $40,742 |
| 2020 | 5 | 570 | 623 | $114,197 | $37,767 |
Total Patients
2,025
Total Services
2,244
Medicare Billing
$145,383
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 165 | $35,770 | $11,676 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $31,412 | $10,277 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 194 | $29,682 | $9,615 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $5,760 | $1,717 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 18 | $2,337 | $922.32 | 39.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $1,903 | $848.21 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 158 | $34,286 | $11,141 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 190 | $29,070 | $9,092 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $28,325 | $8,315 | 29.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $3,712 | $1,366 | 36.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 22 | $2,706 | $1,015 | 37.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,340 | $890.52 | 38.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 179 | 179 | $49,225 | $15,620 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 157 | $33,299 | $11,886 | 35.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 171 | 218 | $32,455 | $11,390 | 35.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 19 | $3,297 | $1,286 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 12 | $1,476 | $560.50 | 38.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 225 | 243 | $44,226 | $14,648 | 33.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 140 | 140 | $38,500 | $13,065 | 33.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 207 | $25,668 | $7,919 | 30.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 16 | $3,712 | $1,343 | 36.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 17 | $2,091 | $791.76 | 37.9% |
About Amy Smith, APRN
Amy Smith, APRN is a Nurse Practitioner healthcare provider based in Georgetown, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972547362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Smith, APRN has received a total of $2,483 in payments from pharmaceutical and medical device companies, with $479.17 received in 2024. These payments were reported across 141 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,483).
As a Medicare-enrolled provider, Smith has provided services to 2,025 Medicare beneficiaries, totaling 2,244 services with total Medicare billing of $145,383. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Georgetown, SC
- Active Since 06/15/2006
- Last Updated 10/01/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1972547362
Products in Payments
- Linzess (Drug) $221.24
- STELARA (Biological) $216.21
- XIFAXAN (Drug) $212.54
- LINZESS (Drug) $183.54
- SUCRAID (Drug) $140.62
- SKYRIZI (Biological) $111.63
- DUPIXENT (Biological) $107.31
- RINVOQ (Biological) $106.41
- MAVYRET (Drug) $103.72
- CREON (Drug) $75.94
- ZEPOSIA (Drug) $64.80
- HETLIOZ (Drug) $64.77
- VIBERZI (Drug) $58.38
- HUMIRA (Biological) $52.30
- REMICADE (Biological) $49.12
- Azstarys (Drug) $35.70
- IBSRELA (Drug) $32.95
- Axonics (Device) $30.26
- MOTEGRITY (Drug) $29.16
- CARDIVA VASCADE 6/7F VCS (Device) $27.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Georgetown
Tricia Greer
Nurse Practitioner — Payments: $10,748
Nurse Practitioner $10,748
Mrs. Michele Lively, Aprn, APRN
Nurse Practitioner — Payments: $4,589
Nurse Practitioner $4,589
Morgan Riley, Aprn, APRN
Nurse Practitioner — Payments: $4,409
Nurse Practitioner $4,409
Logan Ford
Nurse Practitioner — Payments: $3,159
Nurse Practitioner $3,159
Leena Saj, Crnp, CRNP
Nurse Practitioner — Payments: $2,518
Nurse Practitioner $2,518
Melissa Galloway
Nurse Practitioner — Payments: $2,229
Nurse Practitioner $2,229